litlas
Log inCreate account

Christopher A. Ross

Active 1981–2025

243
Papers
56,760
Citations
132
h-index
240
i10-index

Citations

Citations per year for Christopher A. Ross1963: 1 citations1981: 1 citations1982: 5 citations1983: 19 citations1984: 36 citations1985: 40 citations1986: 38 citations1987: 47 citations1988: 63 citations1989: 57 citations1990: 91 citations1991: 121 citations1992: 115 citations1993: 123 citations1994: 124 citations1995: 169 citations1996: 158 citations1997: 260 citations1998: 305 citations1999: 397 citations2000: 413 citations2001: 437 citations2002: 463 citations2003: 549 citations2004: 525 citations2005: 539 citations2006: 619 citations2007: 652 citations2008: 621 citations2009: 634 citations2010: 673 citations2011: 735 citations2012: 581 citations2013: 547 citations2014: 573 citations2015: 428 citations2016: 456 citations2017: 472 citations2018: 473 citations2019: 1,379 citations2020: 1,412 citations2021: 1,360 citations2022: 1,133 citations2023: 778 citations2024: 1,132 citations2025: 545 citations2026: 18 citations1964–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,462 citing papers, 33.3% of this breakdownUnited Kingdom: 1,558 citing papers, 8% of this breakdownGermany: 1,131 citing papers, 5.8% of this breakdownChina: 1,101 citing papers, 5.7% of this breakdownCanada: 877 citing papers, 4.5% of this breakdownItaly: 780 citing papers, 4% of this breakdownJapan: 737 citing papers, 3.8% of this breakdownFrance: 694 citing papers, 3.6% of this breakdownIndia: 517 citing papers, 2.7% of this breakdownAustralia: 494 citing papers, 2.6% of this breakdownSpain: 410 citing papers, 2.1% of this breakdownNetherlands: 391 citing papers, 2% of this breakdown
0%33.3%Other 21.9%

Institutions

Fields

  • Neuroscience37.7%
  • Medicine29%
  • Biochemistry, Genetics and Molecular Biology28.8%
  • Immunology and Microbiology0.8%
  • Psychology0.7%
  • Computer Science0.5%
  • Other2.5%

Topics

  • Genetic Neurodegenerative Diseases10.1%
  • Mitochondrial Function and Pathology6.5%
  • Parkinson's Disease Mechanisms and Treatments5.1%
  • Alzheimer's disease research and treatments3.4%
  • Neurological disorders and treatments3.2%
  • Neuroscience and Neuropharmacology Research2.5%
  • Other69.2%

Coauthors

All papers

Open in search
  1. Huntington disease

    Authors: Gillian P. Bates, Ray Dorsey, James F. Gusella, Michael R. Hayden, Chris Kay, Blair R. Leavitt, Martha Nance, Christopher A. Ross, Rachael I. Scahill, Ronald Wetzel, Edward J. Wild, Sarah J. Tabrizi - Nature Reviews Disease Primers 2015 cited by 1,577

  2. Protein aggregation and neurodegenerative disease

    Authors: Christopher A. Ross, Michelle A. Poirier - Nature Medicine 2004 cited by 3,467

  3. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities

    Authors: Sarah J. Tabrizi, Michael Flower, Christopher A. Ross, Edward J. Wild - Nature Reviews Neurology 2020 cited by 532

  4. Huntington's disease: from molecular pathogenesis to clinical treatment

    Authors: Christopher A. Ross, Sarah J. Tabrizi - The Lancet Neurology 2010 cited by 1,726

  5. A biological classification of Huntington's disease: the Integrated Staging System

    Authors: Sarah J. Tabrizi, Scott Schobel, Emily C. Gantman, Alexandra Mansbach, Beth Borowsky, Pavlina Konstantinova, Tiago Mestre, Jennifer Panagoulias, Christopher A. Ross, Maurice Zauderer, Ariana P. Mullin, Klaus Romero, Sudhir Sivakumaran, Emily C. Turner, Jeffrey D. Long, Cristina Sampaio - The Lancet Neurology 2022 cited by 301

  6. Huntington disease: natural history, biomarkers and prospects for therapeutics

    Authors: Christopher A. Ross, Elizabeth Aylward, Edward J. Wild, Douglas R. Langbehn, Jeffrey D. Long, John Harley Warner, Rachael I. Scahill, Blair R. Leavitt, Julie C. Stout, Jane S. Paulsen, Ralf Reilmann, Paul G. Unschuld, Alice Wexler, Russell L. Margolis, Sarah J. Tabrizi - Nature Reviews Neurology 2014 cited by 1,009

  7. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

    Authors: Andrew B. West, Darren J. Moore, Saskia Biskup, Artem Bugayenko, Wanli W. Smith, Christopher A. Ross, Valina L. Dawson, Ted M. Dawson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 1,238

  8. Mutant Huntingtin Disrupts the Nuclear Pore Complex

    Authors: Jonathan C. Grima, J. Gavin Daigle, Nicolas Arbez, Kathleen M. Cunningham, Ke Zhang, Joseph Ochaba, Charlene Geater, Eva L. Morozko, Jennifer Stocksdale, Jenna Glatzer, Jacqueline T. Pham, Ishrat Ahmed, Peng Qi, Harsh Wadhwa, Olga Pletniková, Juan C. Troncoso, Wenzhen Duan, Solomon H. Snyder, Laura P.W. Ranum, Leslie M. Thompson, Thomas E. Lloyd, Christopher A. Ross, Jeffrey D. Rothstein - Neuron 2017 cited by 371

  9. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

    Authors: Michael Benatar, Joanne Wuu, Caroline McHutchison, Ronald B. Postuma, Bradley F. Boeve, Ronald C. Petersen, Christopher A. Ross, Howard J. Rosen, Jalayne J. Arias, Stephanie Fradette, Michael McDermott, Jeremy M. Shefner, Christine Stanislaw, Sharon Abrahams, Stephanie Cosentino, Peter M Andersen, Richard S. Finkel, Volkan Granit, Anne‐Laure Grignon, Jonathan D. Rohrer, Corey T. McMillan, Murray Grossman, Ammar Al-Chalabi, Martin R. Turner, First International Pre-Symptomatic ALS Workshop, Ammar Al-Chalabi, Peter M Andersen, Jalayne J. Arias, Michael Benatar, Bradley F. Boeve, Stephanie Cosentino, Kuldip D. Dave, Toby A. Ferguson, Mary-Kay Floeter, Jonathan D. Rohrer, Stephanie Fradette, Tania F. Gendron, Volkan Granit, Anne‐Laure Grignon, Murray Grossman, Amelie K. Gubitz, Petra Kaufman, Isabelle Le Ber, Suzee Lee, Andrea Malaspina, Michael McDermott, Caroline McHutchison, Corey T. McMillan, Katie Nicholson, Ronald C. Petersen, Ronald B. Postuma, Richard Robinson, Howard J. Rosen, Christopher A. Ross, Jeremy M. Shefner, Christine Stanislaw, Nadine Tatton, Neil Thakur, Martin R. Turner, Jochen H. Weishaupt, Joanne Wuu - Brain 2021 cited by 116

  10. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation

    Authors: Stephen W. Davies, Mark Turmaine, Barbara A. Cozens, Marian DiFiglia, Alan H. Sharp, Christopher A. Ross, Eberhard Scherzinger, Erich E. Wanker, Laura Mangiarini, Gillian P. Bates - Cell 1997 cited by 2,203

  11. Trinucleotide repeat length instability and age of onset in Huntington's disease

    Authors: Mabel P. Duyao, C M Ambrose, Richard H. Myers, Andrea Novelletto, Francesca Persichetti, Marina Frontali, Susan E. Folstein, Christopher A. Ross, Mary L. Franz, M Abbott, J. Gray, P.M. Conneally, A. B. Young, John B. Penney, Zane Hollingsworth, Ira Shoulson, Alice Lazzarini, Arthur Falek, Walter J. Koroshetz, Daniel S. Sax, Edward J. Bird, Jean Paul Vonsattel, E. Bonilla, José Alvir, Jaime Conde, Jeong‐Heon Cha, Leon Dure, F. Gomez, María Ramos, Juan Sanchez‐Ramos, S. Robert Snodgrass, Margot de Young, Nancy S. Wexler, Chaya Moscowitz, Graciela K. Penchaszadeh, H MacFarlane, Mark J. Anderson, Bruce G. Jenkins, Jayalakshmi Srinidhi, Glenn Barnes, James F. Gusella, Marcy E. MacDonald - Nature Genetics 1993 cited by 1,099

  12. Synaptic dysregulation in a human iPS cell model of mental disorders

    Authors: Zhexing Wen, Ha Nam Nguyen, Ziyuan Guo, Matthew A. Lalli, Xinyuan Wang, Yijing Su, Nam-Shik Kim, Ki‐Jun Yoon, Jaehoon Shin, Ce Zhang, Georgia Makri, David W. Nauen, Huimei Yu, Elmer Guzman, Cheng-Hsuan Chiang, Nadine Yoritomo, Kozo Kaibuchi, Jizhong Zou, Kimberly M. Christian, Linzhao Cheng, Christopher A. Ross, Russell L. Margolis, Gong Chen, Kenneth S. Kosik, Hongjun Song, Guo‐li Ming - Nature 2014 cited by 568

  13. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

    Authors: J.-M. Lee, E.M. Ramos, J.-H. Lee, Tammy Gillis, Jayalakshmi Srinidhi Mysore, Michael R. Hayden, Simon C. Warby, PJ Morrison, Martha Nance, Christopher A. Ross, Russell L. Margolis, Ferdinando Squitieri, S. Orobello, Stefano Di Donato, Estrella Gómez‐Tortosa, Carmen Ayuso, Oksana Suchowersky, R J Trent, Elizabeth McCusker, Andrea Novelletto, Marina Frontali, Randi Jones, Tetsuo Ashizawa, Samuel Frank, Marie Saint‐Hilaire, Steven M. Hersch, H. Diana Rosas, Diane Lucente, Madeline Harrison, Andrea Zanko, Ruth K. Abramson, Karen Marder, Jorge Sequeiros, Jane S. Paulsen, G. Bernhard Landwehrmeyer, Richard H. Myers, Marcy E. MacDonald, James F. Gusella, Alexandra Dürr, Adam Rosenblatt, Luigi Frati, Susan B. Perlman, P. M. Conneally, Mary Lou Klimek, Melissa Diggin, Tiffany C. Hadzi, Ayana Duckett, Anwar Ahmed, Paul Allen, David Ames, Christine Anderson, Karla J. Anderson, Karen Anderson, Thomasin Andrews, John Ashburner, Eric Axelson, Elizabeth Aylward, Roger A. Barker, Katrin Barth, Stacey K. Barton, Kathleen Baynes, Alexandra Bea, Erik B. Beall, Mirza Faisal Beg, Leigh J. Beglinger, Kevin Biglan, K. Björk, Steve Blanchard, Jeremy Bockholt, Sudharshan Reddy Bommu, Bradley G. Brossman, Maggie Burrows, Vince D. Calhoun, Noelle E. Carlozzi, Amy M. Chesire, Edmond Chiu, Phyllis Chua, R.J. Connell, Carmela Connor, Jody Corey‐Bloom, David Craufurd, Stephen Cross, Lucette A. Cysique, Rachelle Dar Santos, Jennifer Davis, Joji Decolongon, A. Dipietro, Nicholas Doucette, Nancy R. Downing, Ann Dudler, Steve Dunn, Daniel Ecker, Eric A. Epping, Diane Erickson, Cheryl Erwin, Kenneth Evans, Stewart A. Factor, Sarah Tomaszewski Farias, Marta Fatas, Jess G. Fiedorowicz and 611 more - Neurology 2012 cited by 391

  14. Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets

    Authors: Mali Jiang, Jiawei Wang, Jinrong Fu, Lin Du, Hyunkyung Jeong, Tim West, Lan Xiang, Peng Qi, Zhipeng Hou, Huan Cai, Tamara Seredenina, Nicolas Arbez, Shanshan Zhu, Katherine Sommers, Jennifer Qian, Jiangyang Zhang, Susumu Mori, X. William Yang, Kellie L. Tamashiro, Susan Aja, Timothy H. Moran, Ruth Luthi‐Carter, Bronwen Martin, Stuart Maudsley, Mark P. Mattson, Robert H. Cichewicz, Christopher A. Ross, David M. Holtzman, Dimitri Krainc, Wenzhen Duan - Nature Medicine 2011 cited by 344

  15. Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington’s disease

    Authors: Rocío Gómez‐Pastor, Eileen T. Burchfiel, Daniel W. Neef, Alex M. Jaeger, Elisa Cabiscol, Spencer U. McKinstry, Argenia L.N. Doss, Alejandro Aballay, Donald C. Lo, Sergey Akimov, Christopher A. Ross, Çağla Eroğlu, Dennis J. Thiele - Nature Communications 2017 cited by 229

  16. Parkin Mediates Nonclassical, Proteasomal-Independent Ubiquitination of Synphilin-1: Implications for Lewy Body Formation

    Authors: Kah Leong Lim, Katherine C. M. Chew, Jeanne M.M. Tan, Cheng Wang, Kenny K. K. Chung, Yi Zhang, Yuji Tanaka, Wanli W. Smith, Simone Engelender, Christopher A. Ross, Valina L. Dawson, Ted M. Dawson - Journal of Neuroscience 2005 cited by 556

  17. RAN Translation in Huntington Disease

    Authors: Mónica Báñez-Coronel, Fatma Ayhan, Alex D. Tarabochia, Tao Zu, B. Pérez, Solaleh Khoramian Tusi, Olga Pletniková, David Borchelt, Christopher A. Ross, Russell L. Margolis, Anthony T. Yachnis, Juan C. Troncoso, Laura P.W. Ranum - Neuron 2015 cited by 352

  18. trans-(−)-ε-Viniferin Increases Mitochondrial Sirtuin 3 (SIRT3), Activates AMP-activated Protein Kinase (AMPK), and Protects Cells in Models of Huntington Disease

    Authors: Jinrong Fu, Jing Jin, Robert H. Cichewicz, Serena A. Hageman, Trevor K. Ellis, Lan Xiang, Peng Qi, Mali Jiang, Nicolas Arbez, Katelyn Hotaling, Christopher A. Ross, Wenzhen Duan - Journal of Biological Chemistry 2012 cited by 209

  19. What is the role of protein aggregation in neurodegeneration?

    Authors: Christopher A. Ross, Michelle A. Poirier - Nature Reviews Molecular Cell Biology 2005 cited by 604

  20. Acute Kidney Injury Leads to Inflammation and Functional Changes in the Brain

    Authors: Manchang Liu, Yideng Liang, Srinivasulu Chigurupati, Justin D. Lathia, Mikhail V. Pletnikov, Zhaoli Sun, Michael T. Crow, Christopher A. Ross, Mark P. Mattson, Hamid Rabb - Journal of the American Society of Nephrology 2008 cited by 396

  21. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

    Authors: Ralf Reilmann, Andrew McGarry, Igor D. Grachev, Juha‐Matti Savola, Beth Borowsky, Eli Eyal, Nicholas J. Gross, Douglas R. Langbehn, Robin Schubert, Anna Teige Wickenberg, Spyros Papapetropoulos, Michael R. Hayden, Ferdinando Squitieri, Karl Kieburtz, G. Bernhard Landwehrmeyer, Pinky Agarwal, Karen E. Anderson, Nasir A Aziz, J.P. Azulay, Anne‐Catherine Bachoud‐Lévi, Roger A. Barker, Agnieszka Bebak, Markus Beuth, Kevin Biglan, Stéphanie Blin, Stefan Bohlen, Raphael M. Bonelli, Sue Caldwell, Fabienne Calvas, Jonielyn Carlos, Simona Castagliuolo, Terrence Chong, Phyllis Chua, Allison Coleman, Jody Corey‐Bloom, Rebecca Cousins, David Craufurd, Jill Davison, E Decorte, Giuseppe De Michele, Laura Dornhege, Andrew Feigin, Stephanie Gallehawk, Pascale Gauteul, Carey Gonzales, Jane Griffith, А.В. Густов, Mark Guttman, Beatrix Heim, Hope Heller, Lena E. Hjermind, С. Н. Иллариошкин, Larry Ivanko, Jessica Jaynes, Mollie W. Jenckes, Barbara J. Kaminski, Anne Kampstra, Agnieszka Konkel, S V Kopishinskaya, Pierre Krystkowiak, Suresh K Komati, Alexander Kwako, Stefan Lakoning, Guzal Latipova, Blair R. Leavitt, Clement T. Loy, Cheryl MacFarlane, Louise Madsen, Karen Marder, Sarah Mason, Neila Mendis, Tilak Mendis, Andrea H. Németh, Louise Nevitt, Virginia Norris, Christine J. O’Neill, Audrey Olivier, Michael Orth, Ashley Owens, Peter K. Panegyres, Susan Perlman, J. Samuel Preston, Josef Priller, Alicja Puch, Oliver Quarrell, Domenica Ragosta, Amandine Rialland, Hugh Rickards, Anna Maria Romoli, Christopher A. Ross, Anne Rosser, Monika Rudzińska, Cinzina V Russo, Carsten Saft, Victoria Segro, Klaus Seppi, Barbara Shannon, David Shprecher, C. Simonin, Zara Skitt and 20 more - The Lancet Neurology 2018 cited by 108

  22. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity

    Authors: Frederick C. Nucifora, Masayuki Sasaki, Matthew F. Peters, Hui Huang, Jillian K. Cooper, Mitsunori Yamada, Hitoshi Takahashi, Shoji Tsuji, Juan C. Troncoso, Valina L. Dawson, Ted M. Dawson, Christopher A. Ross - Science 2001 cited by 1,094

  23. Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease

    Authors: Jiri M.G. Van Bergen, Jun Hua, Paul G. Unschuld, Issel Anne L. Lim, Craig Jones, Russell L. Margolis, Christopher A. Ross, Peter C.M. van Zijl, Xu Li - American Journal of Neuroradiology 2015 cited by 149

  24. Neuroprotective effects of PPAR‐γ agonist rosiglitazone in N171‐82Q mouse model of Huntington's disease

    Authors: Jing Jin, Jennifer Albertz, Zhihong Guo, Peng Qi, Gay Rudow, Juan C. Troncoso, Christopher A. Ross, Wenzhen Duan - Journal of Neurochemistry 2013 cited by 120